Liver Safety of the Dual Neurokinin-1/-3 Receptor Antagonist Elinzanetant - Poll - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Assessment of Hepatic Safety for the Dual Neurokinin-1/-3 Receptor Antagonist Elinzanetant

  • By

  • James H. Lewis

  • Raúl J. Andrade

  • Dominique Larrey

  • Yves Horsmans

  • Richard A. Anderson

  • Mila Trajanovic

  • Esther Groettrup-Wolfers

  • Lineke Zuurman

  • March 18, 2026

Share

Original Source(s)

Related Content